Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-044318
Filing Date
2026-04-16
Accepted
2026-04-16 07:00:16
Documents
3
Period of Report
2026-04-16

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0286617-6k_tiziana.htm 6-K 14428
2 TIZIANA LIFE SCIENCES LTD PRESS RELEASE, DATED APRIL 16, 2026 ea028661701ex99-1.htm EX-99.1 15304
3 GRAPHIC ea028661701_ex99-1img1.jpg GRAPHIC 12597
  Complete submission text file 0001213900-26-044318.txt   48419
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 26865646
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)